WeChat Mini Program
Old Version Features

Synergistic Antitumor Effect of BRMS1 and Sorafenib Via Inhibition of the PI3K/AKT/mTOR/ERK Signaling Pathway.

Jingyun Jin, Yonggang Guo,Yang Liu,Zhenguo Wang,Xiaosa Yang,Shengkai Sun

Oncology Reports（2019）

Cited 4|Views9
Key words
BRMS1,liver cancer cells,sorafenib,antitumor effect,PI3K,AKT,mTOR,ERK signaling pathway
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined